Newsome, P., Francque, S., Harrison, S., Ratziu, V., Van Gaal, L., Calanna, S., . . . Sanyal, A. (2019). Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity. Alimentary pharmacology & therapeutics, 50(2), 193-203. https://doi.org/10.1111/apt.15316
Chicago Style (17th ed.) CitationNewsome, Philip, Sven Francque, Stephen Harrison, Vlad Ratziu, Luc Van Gaal, Salvatore Calanna, Morten Hansen, Martin Linder, and Arun Sanyal. "Effect of Semaglutide on Liver Enzymes and Markers of Inflammation in Subjects with Type 2 Diabetes And/or Obesity." Alimentary Pharmacology & Therapeutics 50, no. 2 (2019): 193-203. https://doi.org/10.1111/apt.15316.
MLA (9th ed.) CitationNewsome, Philip, et al. "Effect of Semaglutide on Liver Enzymes and Markers of Inflammation in Subjects with Type 2 Diabetes And/or Obesity." Alimentary Pharmacology & Therapeutics, vol. 50, no. 2, 2019, pp. 193-203, https://doi.org/10.1111/apt.15316.